StockBaat

Actis, Sequoia plan sale of India pharma stake - Bloomberg: MUMBAI (Reuters) - Private equity companies Actis Capital and Sequoia Capital plan to sell a controlling stake in India's Paras Pharmaceuticals for as much as $700 million, Bloomberg reported on Tuesday. http://bit.ly/cuO4p2